Transplantation and Mechanical Circulatory Support in Congenital Heart Disease: A Scientific Statement from the American Heart Association

Circulation

Volumn 133, Issue 8, 2016, Pages 802-820

  Ross, Heather J ^a   Law, Yuk ^a   Book, Wendy M ^a   Broberg, Craig S ^a   Burchill, Luke ^a   Cecchin, Frank ^a   Chen, Jonathan M ^a   Delgado, Diego ^a   Dimopoulos, Konstantinos ^a   Everitt, Melanie D ^a   Gatzoulis, Michael ^a   Harris, Louise ^a   Hsu, Daphne T ^a   Kuvin, Jeffrey T ^a   Martin, Cindy M ^a   Murphy, Anne M ^a   Singh, Gautam ^a   Spray, Thomas L ^a   Stout, Karen K ^a  

^a NONE

Author keywords

AHA Scientific Statements; congenital heart disease; Fontan procedure; heart failure; heart transplantation; ventricular assist device

Indexed keywords

ARTICLE; ASSISTED CIRCULATION; CONGENITAL HEART DISEASE; EISENMENGER COMPLEX; FONTAN PROCEDURE; HEART SINGLE VENTRICLE; HEART TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; LIVER DISEASE; LUNG VASCULAR RESISTANCE; MECHANICAL CIRCULATORY SUPPORT; MEDICAL SOCIETY; MORTALITY; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT CONTRAINDICATION; TREATMENT INDICATION; EXTRACORPOREAL CIRCULATION; HEART ASSIST DEVICE; HEART DEFECTS, CONGENITAL; PROCEDURES; TRENDS; UNITED STATES;

AMERICAN HEART ASSOCIATION; EXTRACORPOREAL CIRCULATION; HEART DEFECTS, CONGENITAL; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; UNITED STATES;

EID: 84975687960     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000000353     Document Type: Article

References (177)

1. Stout KK, Broberg CS, Book WM, Cecchin F, Chen JM, Dimopoulos K, Everitt MD, Gatzoulis M, Harris L, Hsu DT, Kuvin JT, Law Y, Martin CM, Murphy AM, Ross HJ, Singh G, Spray TL; on behalf of the American Heart Association Council on Clinical Cardiology, Council on Functional Genomics and Translational Biology, and Council on Cardiovascular Radiology and Imaging. Chronic heart failure in congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2016;133:XXX-XXX. doi: 10.1161/CIR.0000000000000352.
2. Opotowsky AR, Siddiqi OK, Webb GD. Trends in hospitalizations for adults with congenital heart disease in the U.S. J Am Coll Cardiol. 2009;54:460-467. doi: 10.1016/j.jacc.2009.04.037.
3. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007;115:163-172. doi: 10.1161/CIRCULATIONAHA.106.627224.
4. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Circulation. 2005;112:e154-e235.
5. Jessup M, Costanzo MR. The cardiorenal syndrome: do we need a change of strategy or a change of tactics J Am Coll Cardiol. 2009;53:597-599. doi: 10.1016/j.jacc.2008.11.012.
6. Karamlou T, Hirsch J, Welke K, Ohye RG, Bove EL, Devaney EJ, Gajarski RJ. A United Network for Organ Sharing analysis of heart transplantation in adults with congenital heart disease: outcomes and factors associated with mortality and retransplantation. J Thorac Cardiovasc Surg. 2010;140:161-168. doi: 10.1016/j.jtcvs.2010.03.036.
7. Everitt MD, Donaldson AE, Stehlik J, Kaza AK, Budge D, Alharethi R, Bullock EA, Kfoury AG, Yetman AT. Would access to device therapies improve transplant outcomes for adults with congenital heart disease Analysis of the United Network for Organ Sharing (UNOS). J Heart Lung Transplant. 2011;30:395-401. doi: 10.1016/j.healun.2010.09.008.
8. Gelow JM, Song HK, Weiss JB, Mudd JO, Broberg CS. Organ allocation in adults with congenital heart disease listed for heart transplant: impact of ventricular assist devices. J Heart Lung Transplant. 2013;32:1059-1064. doi: 10.1016/j.healun.2013.06.024.
9. Davies RR, Russo MJ, Yang J, Quaegebeur JM, Mosca RS, Chen JM. Listing and transplanting adults with congenital heart disease. Circulation. 2011;123:759-767. doi: 10.1161/CIRCULATIONAHA.110.960260.
10. Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI, Dobbels F, Kirk R, Rahmel AO, Hertz MI; International Society of Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report-2012. J Heart Lung Transplant. 2012;31:1052-1064. doi: 10.1016/j.healun.2012.08.002.
11. Singh TP, Almond CS, Taylor DO, Graham DA. Decline in heart transplant wait list mortality in the United States following broader regional sharing of donor hearts. Circ Heart Fail. 2012;5:249-258. doi: 10.1161/CIRCHEARTFAILURE.111.964247.
12. Colvin-Adams M, Smithy JM, Heubner BM, Skeans MA, Edwards LB, Waller C, Schnitzler MA, Snyder JJ, Israni JK, Kasiske BL. OPTN/SRTR 2012 Annual Data Report: heart. Am J Transplant. 2014;14(suppl 1):113-138.
13. Dipchand AI, Kirk R, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dobbels F, Lund LH, Rahmel AO, Yusen RD, Stehlik J; International Society for Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: Sixteenth Official Pediatric Heart Transplantation Report-2013: focus theme: age. J Heart Lung Transplant. 2013;32:979-988. doi: 10.1016/j.healun.2013.08.005.
14. Ohye RG, Schonbeck JV, Eghtesady P, Laussen PC, Pizarro C, Shrader P, Frank DU, Graham EM, Hill KD, Jacobs JP, Kanter KR, Kirsh JA, Lambert LM, Lewis AB, Ravishankar C, Tweddell JS, Williams IA, Pearson GD; Pediatric Heart Network Investigators. Cause, timing, and location of death in the Single Ventricle Reconstruction trial. J Thorac Cardiovasc Surg. 2012;144:907-914. doi: 10.1016/j.jtcvs.2012.04.028.
15. Weinstein S, Bello R, Pizarro C, Fynn-Thompson F, Kirklin J, Guleserian K, Woods R, Tjossem C, Kroslowitz R, Friedmann P, Jaquiss R. The use of the Berlin Heart EXCOR in patients with functional single ventricle. J Thorac Cardiovasc Surg. 2014;147:697-704; discussion 704. doi: 10.1016/j.jtcvs.2013.10.030.
16. Smits JM, de Vries E, De Pauw M, Zuckermann A, Rahmel A, Meiser B, Laufer G, Reichenspurner H, Strueber M. Is it time for a cardiac allocation score First results from the Eurotransplant pilot study on a survival benefit-based heart allocation. J Heart Lung Transplant. 2013;32:873-880. doi: 10.1016/j.healun.2013.03.015.
17. OPTN/UNOS Thoracic Organ Transplantation and Pediatric Transplantation Committees. Proposal to Change Pediatric Heart Allocation Policy. Rockville, MD: US Department of Health & Human Services; 2013. Accessed April 23, 2015. https://www.transplantpro.org/wp-content/uploads/sites/3/2014-06-Thor-Action-Item-Ped-Heart-Changes-replacement.pdf
18. Haddad H, Isaac D, Legare JF, Pflugfelder P, Hendry P, Chan M, Cantin B, Giannetti N, Zieroth S, White M, Warnica W, Doucette K, Rao V, Dipchand A, Cantarovich M, Kostuk W, Cecere R, Charbonneau E, Ross H, Poirier N. Canadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: Executive Summary. Can J Cardiol. 2009;25:197-205.
19. Chih S, Ross HJ, McDonald MA, Isaac DL. Highly sensitized patients in cardiac transplantation: early outcomes from the Canadian Prioritized Organ Sharing Program. J Heart Lung Transplant. 2012;31:780-782. doi: 10.1016/j.healun.2012.02.017.
20. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 Focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009;119:1977-2016. doi: 10.1161/CIRCULATIONAHA.109.192064.
21. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:1810-1852. doi: 10.1161/CIR.0b013e31829e8807.
22. Rosenthal D, Chrisant MR, Edens E, Mahony L, Canter C, Colan S, Dubin A, Lamour J, Ross R, Shaddy R, Addonizio L, Beerman L, Berger S, Bernstein D, Blume E, Boucek M, Checchia P, Dipchand A, Drummond-Webb J, Fricker J, Friedman R, Hallowell S, Jaquiss R, Mital S, Pahl E, Pearce FB, Pearce B, Rhodes L, Rotondo K, Rusconi P, Scheel J, Pal Singh T, Towbin J. International Society for Heart and Lung Transplantation: practice guidelines for management of heart failure in children [published correction appears in J Heart Lung Transplant. 2009;28:987]. J Heart Lung Transplant. 2004;23:1313-1333. doi: 10.1016/j.healun.2004.03.018.
23. Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, Mohacsi P, Augustine S, Aaronson K, Barr M. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant. 2006;25:1024-1042. doi: 10.1016/j.healun.2006.06.008.
24. Canter CE, Shaddy RE, Bernstein D, Hsu DT, Chrisant MR, Kirklin JK, Kanter KR, Higgins RS, Blume ED, Rosenthal DN, Boucek MM, Uzark KC, Friedman AH, Friedman AH, Young JK. Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group [published correction appears in Circulation. 2007;115:e385]. Circulation. 2007;115:658-676. doi: 10.1161/CIRCULATIONAHA.106.180449.
25. Michielon G, Parisi F, Squitieri C, Carotti A, Gagliardi G, Pasquini L, Di Donato RM. Orthotopic heart transplantation for congenital heart disease: an alternative for high-risk Fontan candidates Circulation. 2003;108(suppl 1):II140-II149. doi: 10.1161/01.cir.0000087442.82569.51.
26. Chungsomprasong P, Soongswang J, Nana A, Durongpisitkul K, Loahaprasitiporn D, Vijansorn C, Sriyodchartti S. Medium and long-term outcomes of Fontan operation. J Med Assoc Thai. 2011;94:323-330.
27. Nakano T, Kado H, Tachibana T, Hinokiyama K, Shiose A, Kajimoto M, Ando Y. Excellent midterm outcome of extracardiac conduit total cavopulmonary connection: results of 126 cases. Ann Thorac Surg. 2007;84:1619-1625. doi: 10.1016/j.athoracsur.2007.05.074.
28. d'Udekem Y, Iyengar AJ, Cochrane AD, Grigg LE, Ramsay JM, Wheaton GR, Penny DJ, Brizard CP. The Fontan procedure: contemporary techniques have improved long-term outcomes. Circulation. 2007;116(suppl):I157-I164. doi: 10.1161/CIRCULATIONAHA.106.676445.
29. Giannico S, Hammad F, Amodeo A, Michielon G, Drago F, Turchetta A, Di Donato R, Sanders SP. Clinical outcome of 193 extracardiac Fontan patients: the first 15 years. J Am Coll Cardiol. 2006;47:2065-2073. doi: 10.1016/j.jacc.2005.12.065.
30. Kim SJ, Kim WH, Lim HG, Lee JY. Outcome of 200 patients after an extracardiac Fontan procedure. J Thorac Cardiovasc Surg. 2008;136:108-116. doi: 10.1016/j.jtcvs.2007.12.032.
31. Petko M, Myung RJ, Wernovsky G, Cohen MI, Rychik J, Nicolson SC, Gaynor JW, Spray TL. Surgical reinterventions following the Fontan procedure. Eur J Cardiothorac Surg. 2003;24:255-259.
32. Mavroudis C, Backer CL, Deal BJ, Johnsrude C, Strasburger J. Total cavopulmonary conversion and maze procedure for patients with failure of the Fontan operation. J Thorac Cardiovasc Surg. 2001;122:863-871. doi: 10.1067/mtc.2001.117840.
33. Mavroudis C, Stewart RD, Backer CL, Deal BJ, Young L, Franklin WH. Atrioventricular valve procedures with repeat Fontan operations: influence of valve pathology, ventricular function, and arrhythmias on outcome. Ann Thorac Surg. 2005;80:29-36.
34. Bernstein D, Naftel D, Chin C, Addonizio LJ, Gamberg P, Blume ED, Hsu D, Canter CE, Kirklin JK, Morrow WR; Pediatric Heart Transplant Study. Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation. 2006;114:273-280. doi: 10.1161/CIRCULATIONAHA.105.548016.
35. Kovach JR, Naftel DC, Pearce FB, Tresler MA, Edens RE, Shuhaiber JH, Blume ED, Fynn-Thompson F, Kirklin JK, Zangwill SD. Comparison of risk factors and outcomes for pediatric patients listed for heart transplantation after bidirectional Glenn and after Fontan: an analysis from the Pediatric Heart Transplant Study. J Heart Lung Transplant. 2012;31:133-139. doi: 10.1016/j.healun.2011.11.004.
36. Davies RR, Sorabella RA, Yang J, Mosca RS, Chen JM, Quaegebeur JM. Outcomes after transplantation for "failed" Fontan: a single-institution experience. J Thorac Cardiovasc Surg. 2012;143:1183-1192.e4. doi: 10.1016/j.jtcvs.2011.12.039.
37. Carey JA, Hamilton JR, Hilton CJ, Dark JH, Forty J, Parry G, Hasan A. Orthotopic cardiac transplantation for the failing Fontan circulation. Eur J Cardiothorac Surg. 1998;14:7-13.
38. Kanter KR, Mahle WT, Vincent RN, Berg AM, Kogon BE, Kirshbom PM. Heart transplantation in children with a Fontan procedure. Ann Thorac Surg. 2011;91:823-829. doi: 10.1016/j.athoracsur.2010.11.031.
39. Chaudhari M, Sturman J, O'Sullivan J, Smith J, Wrightson N, Parry G, Bolton D, Haynes S, Hamilton L, Hasan A. Rescue cardiac transplantation for early failure of the Fontan-type circulation in children. J Thorac Cardiovasc Surg. 2005;129:416-422. doi: 10.1016/j.jtcvs.2004.06.030.
40. Gossett JG, Almond CS, Kirk R, Zangwill S, Richmond ME, Kantor PF, Tresler MA, Lenderman SM, Naftel DC, Matthews KL, Pahl E. Outcomes of cardiac transplantation in single-ventricle patients with plastic bronchitis: a multicenter study. J Am Coll Cardiol. 2013;61:985-986. doi: 10.1016/j.jacc.2012.10.042.
41. Chrisant MR, Naftel DC, Drummond-Webb J, Chinnock R, Canter CE, Boucek MM, Boucek RJ, Hallowell SC, Kirklin JK, Morrow WR; Pediatric Heart Transplant Study Group. Fate of infants with hypoplastic left heart syndrome listed for cardiac transplantation: a multicenter study. J Heart Lung Transplant. 2005;24:576-582. doi: 10.1016/j. healun.2004.01.019.
42. Ashburn DA, McCrindle BW, Tchervenkov CI, Jacobs ML, Lofland GK, Bove EL, Spray TL, Williams WG, Blackstone EH. Outcomes after the Norwood operation in neonates with critical aortic stenosis or aortic valve atresia. J Thorac Cardiovasc Surg. 2003;125:1070-1082. doi: 10.1067/mtc.2003.183.
43. Ohye RG, Sleeper LA, Mahony L, Newburger JW, Pearson GD, Lu M, Goldberg CS, Tabbutt S, Frommelt PC, Ghanayem NS, Laussen PC, Rhodes JF, Lewis AB, Mital S, Ravishankar C, Williams IA, Dunbar-Masterson C, Atz AM, Colan S, Minich LL, Pizarro C, Kanter KR, Jaggers J, Jacobs JP, Krawczeski CD, Pike N, McCrindle BW, Virzi L, Gaynor JW; Pediatric Heart Network Investigators. Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med. 2010;362:1980-1992. doi: 10.1056/NEJMoa0912461.
44. Newburger JW, Sleeper LA, Frommelt PC, Pearson GD, Mahle WT, Chen S, Dunbar-Masterson C, Mital S, Williams IA, Ghanayem NS, Goldberg CS, Jacobs JP, Krawczeski CD, Lewis AB, Pasquali SK, Pizarro C, Gruber PJ, Atz AM, Khaikin S, Gaynor JW, Ohye RG; Pediatric Heart Network Investigators. Transplantation-free survival and interventions at 3 years in the single ventricle reconstruction trial. Circulation. 2014;129:2013-2020. doi: 10.1161/CIRCULATIONAHA.113.006191.
45. Jacobs JP, Quintessenza JA, Chai PJ, Lindberg HL, Asante-Korang A, McCormack J, Dadlani G, Boucek RJ. Rescue cardiac transplantation for failing staged palliation in patients with hypoplastic left heart syndrome. Cardiol Young. 2006;16:556-562. doi: 10.1017/S1047951106001223.
46. McHugh KE, Hillman DG, Gurka MJ, Gutgesell HP. Three-stage palliation of hypoplastic left heart syndrome in the University HealthSystem Consortium. Congenit Heart Dis. 2010;5:8-15. doi: 10.1111/j.1747-0803.2009.00367.x.
47. Everitt MD, Boyle GJ, Schechtman KB, Zheng J, Bullock EA, Kaza AK, Dipchand AI, Naftel DC, Kirklin JK, Canter CE; Pediatric Heart Transplant Study Investigators. Early survival after heart transplant in young infants is lowest after failed single-ventricle palliation: a multiinstitutional study. J Heart Lung Transplant. 2012;31:509-516. doi: 10.1016/j.healun.2011.12.013.
48. Bourke KD, Sondheimer HM, Ivy DD, Pietra B, Gleason BK, Mashburn C, Boucek MM. Improved pretransplant management of infants with hypoplastic left heart syndrome enables discharge to home while waiting for transplantation. Pediatr Cardiol. 2003;24:538-543. doi: 10.1007/s00246-003-0449-8.
49. Galantowicz M, Cheatham JP, Phillips A, Cua CL, Hoffman TM, Hill SL, Rodeman R. Hybrid approach for hypoplastic left heart syndrome: intermediate results after the learning curve. Ann Thorac Surg. 2008;85:2063-2070. doi: 10.1016/j.athoracsur.2008.02.009.
50. Karamlou T, Overman D, Hill KD, Wallace A, Pasquali SK, Jacobs JP, Jacobs ML, Caldarone CA. Stage 1 hybrid palliation for hypoplastic left heart syndrome: assessment of contemporary patterns of use: an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database. J Thorac Cardiovasc Surg. 2015;149:195-202.e1. doi: 10.1016/j. jtcvs.2014.08.020.
51. Davies RR, Radtke W, Bhat MA, Baffa JM, Woodford E, Pizarro C. Hybrid palliation for critical systemic outflow obstruction: neither rapid stage 1 Norwood nor comprehensive stage 2 mitigate consequences of early risk factors. J Thorac Cardiovasc Surg. 2015;149:182-191. doi: 10.1016/j.jtcvs.2014.09.030.
52. Schranz D, Bauer A, Reich B, Steinbrenner B, Recla S, Schmidt D, Apitz C, Thul J, Valeske K, Bauer J, Müller M, Jux C, Michel-Behnke I, Akintürk H. Fifteen-year single center experience with the "Giessen Hybrid" approach for hypoplastic left heart and variants: current strategies and outcomes. Pediatr Cardiol. 2015;36:365-373. doi: 10.1007/s00246-014-1015-2.
53. Ekman Joelsson BM, Sunnegårdh J, Hanseus K, Berggren H, Jonzon A, Jögi P, Lundell B. The outcome of children born with pulmonary atresia and intact ventricular septum in Sweden from 1980 to 1999. Scand Cardiovasc J. 2001;35:192-198.
54. Bull C, Kostelka M, Sorensen K, de Leval M. Outcome measures for the neonatal management of pulmonary atresia with intact ventricular septum. J Thorac Cardiovasc Surg. 1994;107:359-366.
55. Ashburn DA, Blackstone EH, Wells WJ, Jonas RA, Pigula FA, Manning PB, Lofland GK, Williams WG, McCrindle BW; Congenital Heart Surgeons Study members. Determinants of mortality and type of repair in neonates with pulmonary atresia and intact ventricular septum. J Thorac Cardiovasc Surg. 2004;127:1000-1007. doi: 10.1016/j. jtcvs.2003.11.057.
56. Guleserian KJ, Armsby LB, Thiagarajan RR, del Nido PJ, Mayer JE Jr. Natural history of pulmonary atresia with intact ventricular septum and right-ventricle-dependent coronary circulation managed by the singleventricle approach. Ann Thorac Surg. 2006;81:2250-2257. doi: 10.1016/j. athoracsur.2005.11.041.
57. Jahangiri M, Zurakowski D, Bichell D, Mayer JE, del Nido PJ, Jonas RA. Improved results with selective management in pulmonary atresia with intact ventricular septum. J Thorac Cardiovasc Surg. 1999;118:1046-1055. doi: 10.1016/S0022-5223(99)70100-5.
58. Rychik J, Levy H, Gaynor JW, DeCampli WM, Spray TL. Outcome after operations for pulmonary atresia with intact ventricular septum. J Thorac Cardiovasc Surg. 1998;116:924-931. doi: 10.1016/S0022-5223(98)70042-X.
59. Gilljam T, McCrindle BW, Smallhorn JF, Williams WG, Freedom RM. Outcomes of left atrial isomerism over a 28-year period at a single institution. J Am Coll Cardiol. 2000;36:908-916.
60. Hashmi A, Abu-Sulaiman R, McCrindle BW, Smallhorn JF, Williams WG, Freedom RM. Management and outcomes of right atrial isomerism: a 26-year experience. J Am Coll Cardiol. 1998;31:1120-1126.
61. Lodge AJ, Rychik J, Nicolson SC, Ittenbach RF, Spray TL, Gaynor JW. Improving outcomes in functional single ventricle and total anomalous pulmonary venous connection. Ann Thorac Surg. 2004;78:1688-1695. doi: 10.1016/j.athoracsur.2004.04.057.
62. Larsen RL, Eguchi JH, Mulla NF, Johnston JK, Fitts J, Kuhn MA, Razzouk AJ, Chinnock RE, Bailey LL. Usefulness of cardiac transplantation in children with visceral heterotaxy (asplenic and polysplenic syndromes and single right-sided spleen with levocardia) and comparison of results with cardiac transplantation in children with dilated cardiomyopathy. Am J Cardiol. 2002;89:1275-1279.
63. Tutarel O, Kempny A, Alonso-Gonzalez R, Jabbour R, Li W, Uebing A, Dimopoulos K, Swan L, Gatzoulis MA, Diller GP. Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality. Eur Heart J. 2014;35:725-732. doi: 10.1093/eurheartj/eht257.
64. Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, Rosenthal M, Nakazawa M, Moller JH, Gillette PC, Webb GD, Redington AN. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000;356:975-981. doi: 10.1016/S0140-6736(00)02714-8.
65. Bouchardy J, Therrien J, Pilote L, Ionescu-Ittu R, Martucci G, Bottega N, Marelli AJ. Atrial arrhythmias in adults with congenital heart disease. Circulation. 2009;120:1679-1686. doi: 10.1161/CIRCULATIONAHA.109.866319.
66. Giannakoulas G, Dimopoulos K, Yuksel S, Inuzuka R, Pijuan-Domenech A, Hussain W, Tay EL, Gatzoulis MA, Wong T. Atrial tachyarrhythmias late after Fontan operation are related to increase in mortality and hospitalization. Int J Cardiol. 2012;157:221-226. doi: 10.1016/j. ijcard.2010.12.049.
67. Valente AM, Gauvreau K, Assenza GE, Babu-Narayan SV, Schreier J, Gatzoulis MA, Groenink M, Inuzuka R, Kilner PJ, Koyak Z, Landzberg MJ, Mulder B, Powell AJ, Wald R, Geva T. Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort. Heart. 2014;100:247-253. doi: 10.1136/heartjnl-2013-304958.
68. Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in tetralogy of Fallot: QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995;92:231-237.
69. Schwerzmann M, Salehian O, Harris L, Siu SC, Williams WG, Webb GD, Colman JM, Redington A, Silversides CK. Ventricular arrhythmias and sudden death in adults after a Mustard operation for transposition of the great arteries. Eur Heart J. 2009;30:1873-1879. doi: 10.1093/eurheartj/ehp179.
70. Zomer AC, Vaartjes I, van der Velde ET, de Jong HM, Konings TC, Wagenaar LJ, Heesen WF, Eerens F, Baur LH, Grobbee DE, Mulder BJ. Heart failure admissions in adults with congenital heart disease; risk factors and prognosis. Int J Cardiol. 2013;168:2487-2493. doi: 10.1016/j. ijcard.2013.03.003.
71. Lowe BS, Therrien J, Ionescu-Ittu R, Pilote L, Martucci G, Marelli AJ. Diagnosis of pulmonary hypertension in the congenital heart disease adult population: impact on outcomes. J Am Coll Cardiol. 2011;58:538-546. doi: 10.1016/j.jacc.2011.03.033.
72. Alonso-Gonzalez R, Borgia F, Diller GP, Inuzuka R, Kempny A, Martinez-Naharro A, Tutarel O, Marino P, Wustmann K, Charalambides M, Silva M, Swan L, Dimopoulos K, Gatzoulis MA. Abnormal lung function in adults with congenital heart disease: prevalence, relation to cardiac anatomy, and association with survival. Circulation. 2013;127:882-890. doi: 10.1161/CIRCULATIONAHA.112.126755.
73. Babu-Narayan SV, Goktekin O, Moon JC, Broberg CS, Pantely GA, Pennell DJ, Gatzoulis MA, Kilner PJ. Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries. Circulation. 2005;111:2091-2098. doi: 10.1161/01. CIR.0000162463.61626.3B.
74. Giardini A, Lovato L, Donti A, Formigari R, Oppido G, Gargiulo G, Picchio FM, Fattori R. Relation between right ventricular structural alterations and markers of adverse clinical outcome in adults with systemic right ventricle and either congenital complete (after Senning operation) or congenitally corrected transposition of the great arteries. Am J Cardiol. 2006;98:1277-1282. doi: 10.1016/j.amjcard.2006.05.062.
75. Babu-Narayan SV, Kilner PJ, Li W, Moon JC, Goktekin O, Davlouros PA, Khan M, Ho SY, Pennell DJ, Gatzoulis MA. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome. Circulation. 2006;113:405-413. doi: 10.1161/CIRCULATIONAHA.105.548727.
76. Diller GP, Kempny A, Liodakis E, Alonso-Gonzalez R, Inuzuka R, Uebing A, Orwat S, Dimopoulos K, Swan L, Li W, Gatzoulis MA, Baumgartner H. Left ventricular longitudinal function predicts life-threatening ventricular arrhythmia and death in adults with repaired tetralogy of Fallot. Circulation. 2012;125:2440-2446. doi: 10.1161/CIRCULATIONAHA.111.086983.
77. Diller GP, Radojevic J, Kempny A, Alonso-Gonzalez R, Emmanouil L, Orwat S, Swan L, Uebing A, Li W, Dimopoulos K, Gatzoulis MA, Baumgartner H. Systemic right ventricular longitudinal strain is reduced in adults with transposition of the great arteries, relates to subpulmonary ventricular function, and predicts adverse clinical outcome. Am Heart J. 2012;163:859-866. doi: 10.1016/j.ahj.2012.01.038.
78. Moceri P, Dimopoulos K, Liodakis E, Germanakis I, Kempny A, Diller GP, Swan L, Wort SJ, Marino PS, Gatzoulis MA, Li W. Echocardiographic predictors of outcome in Eisenmenger syndrome. Circulation. 2012;126:1461-1468. doi: 10.1161/CIRCULATIONAHA.112.091421.
79. Dimopoulos K, Diller GP, Petraco R, Koltsida E, Giannakoulas G, Tay EL, Best N, Piepoli MF, Francis DP, Poole-Wilson PA, Gatzoulis MA. Hyponatraemia: a strong predictor of mortality in adults with congenital heart disease. Eur Heart J. 2010;31:595-601. doi: 10.1093/eurheartj/ehp495.
80. Dimopoulos K, Diller GP, Giannakoulas G, Petraco R, Chamaidi A, Karaoli E, Mullen M, Swan L, Piepoli MF, Poole-Wilson PA, Francis DP, Gatzoulis MA. Anemia in adults with congenital heart disease relates to adverse outcome. J Am Coll Cardiol. 2009;54:2093-2100. doi: 10.1016/j. jacc.2009.06.050.
81. Dimopoulos K, Diller GP, Koltsida E, Pijuan-Domenech A, Papadopoulou SA, Babu-Narayan SV, Salukhe TV, Piepoli MF, Poole-Wilson PA, Best N, Francis DP, Gatzoulis MA. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation. 2008;117:2320-2328. doi: 10.1161/CIRCULATIONAHA.107.734921.
82. Schuuring MJ, van Riel AC, Vis JC, Duffels MG, van Straalen JP, Boekholdt SM, Tijssen JG, Mulder BJ, Bouma BJ. High-sensitivity troponin T is associated with poor outcome in adults with pulmonary arterial hypertension due to congenital heart disease. Congenit Heart Dis. 2013;8:520-526. doi: 10.1111/chd.12022.
83. Giannakoulas G, Dimopoulos K, Bolger AP, Tay EL, Inuzuka R, Bedard E, Davos C, Swan L, Gatzoulis MA. Usefulness of natriuretic peptide levels to predict mortality in adults with congenital heart disease. Am J Cardiol. 2010;105:869-873. doi: 10.1016/j.amjcard.2009.11.041.
84. Diller GP, Alonso-Gonzalez R, Kempny A, Dimopoulos K, Inuzuka R, Giannakoulas G, Castle L, Lammers AE, Hooper J, Uebing A, Swan L, Gatzoulis M, Wort SJ. B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients: predictive value and response to disease targeting therapy. Heart. 2012;98:736-742. doi: 10.1136/heartjnl-2011-301522.
85. Reardon LC, Williams RJ, Houser LS, Miner PD, Child JS, Aboulhosn JA. Usefulness of serum brain natriuretic peptide to predict adverse events in patients with the Eisenmenger syndrome. Am J Cardiol. 2012;110:1523-1526. doi: 10.1016/j.amjcard.2012.06.061.
86. Eindhoven JA, van den Bosch AE, Ruys TP, Opi P, Cuypers JA, McGhie JS, Witsenburg M, Boersma E, Roos-Hesselink JW. N-terminal pro-Btype natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease. J Am Coll Cardiol. 2013;62:1203-1212. doi: 10.1016/j.jacc.2013.07.019.
87. Eindhoven JA, van den Bosch AE, Jansen PR, Boersma E, Roos-Hesselink JW. The usefulness of brain natriuretic peptide in complex congenital heart disease: a systematic review. J Am Coll Cardiol. 2012;60:2140-2149. doi: 10.1016/j.jacc.2012.02.092.
88. Kempny A, Dimopoulos K, Alonso-Gonzalez R, Alvarez-Barredo M, Tutarel O, Uebing A, Piatek P, Marino P, Swan L, Diller GP, Wort SJ, Gatzoulis MA. Six-minute walk test distance and resting oxygen saturations but not functional class predict outcome in adult patients with Eisenmenger syndrome. Int J Cardiol. 2013;168:4784-4789. doi: 10.1016/j.ijcard.2013.07.227.
89. van der Bom T, Winter MM, Groenink M, Vliegen HW, Pieper PG, van Dijk AP, Sieswerda GT, Roos-Hesselink JW, Zwinderman AH, Mulder BJ, Bouma BJ. Right ventricular end-diastolic volume combined with peak systolic blood pressure during exercise identifies patients at risk for complications in adults with a systemic right ventricle. J Am Coll Cardiol. 2013;62:926-936. doi: 10.1016/j.jacc.2013.06.026.
90. Inuzuka R, Diller GP, Borgia F, Benson L, Tay EL, Alonso-Gonzalez R, Silva M, Charalambides M, Swan L, Dimopoulos K, Gatzoulis MA. Comprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term. Circulation. 2012;125:250-259. doi: 10.1161/CIRCULATIONAHA.111.058719.
91. Diller GP, Dimopoulos K, Okonko D, Li W, Babu-Narayan SV, Broberg CS, Johansson B, Bouzas B, Mullen MJ, Poole-Wilson PA, Francis DP, Gatzoulis MA. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation. 2005;112:828-835. doi: 10.1161/CIRCULATIONAHA.104.529800.
92. Fernandes SM, Alexander ME, Graham DA, Khairy P, Clair M, Rodriguez E, Pearson DD, Landzberg MJ, Rhodes J. Exercise testing identifies patients at increased risk for morbidity and mortality following Fontan surgery. Congenit Heart Dis. 2011;6:294-303. doi: 10.1111/j.1747-0803.2011.00500.x.
93. Giardini A, Specchia S, Tacy TA, Coutsoumbas G, Gargiulo G, Donti A, Formigari R, Bonvicini M, Picchio FM. Usefulness of cardiopulmonary exercise to predict long-term prognosis in adults with repaired tetralogy of Fallot. Am J Cardiol. 2007;99:1462-1467. doi: 10.1016/j. amjcard.2006.12.076.
94. Radojevic J, Inuzuka R, Alonso-Gonzalez R, Borgia F, Giannakoulas G, Prapa M, Liodakis E, Li W, Swan L, Diller GP, Dimopoulos K, Gatzoulis MA. Peak oxygen uptake correlates with disease severity and predicts outcome in adult patients with Ebstein's anomaly of the tricuspid valve. Int J Cardiol. 2013;163:305-308. doi: 10.1016/j.ijcard.2011.06.047.
95. Dimopoulos K, Okonko DO, Diller GP, Broberg CS, Salukhe TV, Babu-Narayan SV, Li W, Uebing A, Bayne S, Wensel R, Piepoli MF, Poole-Wilson PA, Francis DP, Gatzoulis MA. Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predicts survival. Circulation. 2006;113:2796-2802. doi: 10.1161/CIRCULATIONAHA.105.594218.
96. Giardini A, Hager A, Lammers AE, Derrick G, Müller J, Diller GP, Dimopoulos K, Odendaal D, Gargiulo G, Picchio FM, Gatzoulis MA. Ventilatory efficiency and aerobic capacity predict event-free survival in adults with atrial repair for complete transposition of the great arteries. J Am Coll Cardiol. 2009;53:1548-1555. doi: 10.1016/j.jacc.2009.02.005.
97. Diller GP, Dimopoulos K, Okonko D, Uebing A, Broberg CS, Babu-Narayan S, Bayne S, Poole-Wilson PA, Sutton R, Francis DP, Gatzoulis MA. Heart rate response during exercise predicts survival in adults with congenital heart disease. J Am Coll Cardiol. 2006;48:1250-1256. doi: 10.1016/j.jacc.2006.05.051.
98. Giardini A, Specchia S, Berton E, Sangiorgi D, Coutsoumbas G, Gargiulo G, Oppido G, Bonvicini M, Picchio FM. Strong and independent prognostic value of peak circulatory power in adults with congenital heart disease. Am Heart J. 2007;154:441-447. doi: 10.1016/j. ahj.2007.05.009.
99. Kempny A, Dimopoulos K, Uebing A, Moceri P, Swan L, Gatzoulis MA, Diller GP. Reference values for exercise limitations among adults with congenital heart disease: relation to activities of daily life: single centre experience and review of published data. Eur Heart J. 2012;33:1386-1396. doi: 10.1093/eurheartj/ehr461.
100. Mital S, Addonizio LJ, Lamour JM, Hsu DT. Outcome of children with end-stage congenital heart disease waiting for cardiac transplantation. J Heart Lung Transplant. 2003;22:147-153.
101. Almond CS, Thiagarajan RR, Piercey GE, Gauvreau K, Blume ED, Bastardi HJ, Fynn-Thompson F, Singh TP. Waiting list mortality among children listed for heart transplantation in the United States. Circulation. 2009;119:717-727. doi: 10.1161/CIRCULATIONAHA.108.815712.
102. Lamour JM, Kanter KR, Naftel DC, Chrisant MR, Morrow WR, Clemson BS, Kirklin JK; Cardiac Transplant Registry Database; Pediatric Heart Transplant Study. The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease. J Am Coll Cardiol. 2009;54:160-165. doi: 10.1016/j. jacc.2009.04.020.
103. Chen JM, Davies RR, Mital SR, Mercando ML, Addonizio LJ, Pinney SP, Hsu DT, Lamour JM, Quaegebeur JM, Mosca RS. Trends and outcomes in transplantation for complex congenital heart disease: 1984 to 2004. Ann Thorac Surg. 2004;78:1352-1361. doi: 10.1016/j. athoracsur.2004.04.012.
104. Karamlou T, Diggs BS, Ungerleider RM, Welke KF. Adults or big kids: what is the ideal clinical environment for management of grown-up patients with congenital heart disease Ann Thorac Surg. 2010;90:573-579. doi: 10.1016/j.athoracsur.2010.02.078.
105. Kogon BE, Plattner C, Leong T, Kirshbom PM, Kanter KR, McConnell M, Book W. Adult congenital heart surgery: adult or pediatric facility Adult or pediatric surgeon Ann Thorac Surg. 2009;87:833-840. doi: 10.1016/j.athoracsur.2008.12.027.
106. Mylotte D, Pilote L, Ionescu-Ittu R, Abrahamowicz M, Khairy P, Therrien J, Mackie AS, Marelli A. Specialized adult congenital heart disease care: the impact of policy on mortality. Circulation. 2014;129:1804-1812. doi: 10.1161/CIRCULATIONAHA.113.005817.
107. Weiss ES, Meguid RA, Patel ND, Russell SD, Shah AS, Baumgartner WA, Conte JV. Increased mortality at low-volume orthotopic heart transplantation centers: should current standards change Ann Thorac Surg. 2008;86:1250-1259.
108. Patel ND, Weiss ES, Allen JG, Russell SD, Shah AS, Vricella LA, Conte JV. Heart transplantation for adults with congenital heart disease: analysis of the United Network for Organ Sharing database. Ann Thorac Surg. 2009;88:814-821. doi: 10.1016/j.athoracsur.2009.04.071.
109. Meyer SR, Campbell PM, Rutledge JM, Halpin AM, Hawkins LE, Lakey JR, Rebeyka IM, Ross DB. Use of an allograft patch in repair of hypoplastic left heart syndrome may complicate future transplantation. Eur J Cardiothorac Surg. 2005;27:554-560. doi: 10.1016/j. ejcts.2004.12.033.
110. Nwakanma LU, Williams JA, Weiss ES, Russell SD, Baumgartner WA, Conte JV. Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. Ann Thorac Surg. 2007;84:1556-1562. doi: 10.1016/j.athoracsur.2007.05.095.
111. O'Connor MJ, Lind C, Tang X, Gossett J, Weber J, Monos D, Shaddy RE. Persistence of anti-human leukocyte antibodies in congenital heart disease late after surgery using allografts and whole blood. J Heart Lung Transplant. 2013;32:390-397. doi: 10.1016/j.healun.2012.12.009.
112. Rossano JW, Morales DL, Zafar F, Denfield SW, Kim JJ, Jefferies JL, Dreyer WJ. Impact of antibodies against human leukocyte antigens on long-term outcome in pediatric heart transplant patients: an analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg. 2010;140:694-699, 699.e1-699.e2. doi: 10.1016/j.jtcvs.2010.04.009.
113. Kfoury AG, Stehlik J, Renlund DG, Snow G, Seaman JT, Gilbert EM, Stringham JS, Long JW, Hammond ME. Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns. J Heart Lung Transplant. 2006;25:1277-1282. doi: 10.1016/j.healun.2006.08.009.
114. Wu GW, Kobashigawa JA, Fishbein MC, Patel JK, Kittleson MM, Reed EF, Kiyosaki KK, Ardehali A. Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes. J Heart Lung Transplant. 2009;28:417-422. doi: 10.1016/j.healun.2009.01.015.
115. Stastny P, Lavingia B, Fixler DE, Yancy CW, Ring WS. Antibodies against donor human leukocyte antigens and the outcome of cardiac allografts in adults and children. Transplantation. 2007;84:738-745. doi: 10.1097/01.tp.0000281918.51138.3f.
116. Tambur AR, Pamboukian SV, Costanzo MR, Herrera ND, Dunlap S, Montpetit M, Heroux A. The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome. Transplantation. 2005;80:1019-1025.
117. Smith JD, Banner NR, Hamour IM, Ozawa M, Goh A, Robinson D, Terasaki PI, Rose ML. De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival. Am J Transplant. 2011;11:312-319. doi: 10.1111/j.1600-6143.2010.03383.x.
118. Ross H, Tinckam K, Rao V, West LJ. In praise of ventricular assist devices: mechanical bridge to virtual crossmatch for the sensitized patient. J Heart Lung Transplant. 2010;29:728-730. doi: 10.1016/j. healun.2010.02.006.
119. van Riel AC, Schuuring MJ, van Hessen ID, Zwinderman AH, Cozijnsen L, Reichert CL, Hoorntje JC, Wagenaar LJ, Post MC, van Dijk AP, Hoendermis ES, Mulder BJ, Bouma BJ. Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification. Int J Cardiol. 2014;174:299-305. doi: 10.1016/j.ijcard.2014.04.072.
120. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, Olschewski H, Robbins IM, Souza R. Updated clinical classification of pulmonary hypertension [published correction appears in J Am Coll Cardiol. 2014;63:746]. J Am Coll Cardiol. 2013;62(suppl):D34-D41. doi: 10.1016/j.jacc.2013.10.029.
121. Buddhe S, Du W, L'Ecuyer T. Impact of pulmonary hypertension on transplant outcomes in pediatric cardiomyopathy patients. Pediatr Transplant. 2012;16:367-372. doi: 10.1111/j.1399-3046.2012.01678.x.
122. Ofori-Amanfo G, Hsu D, Lamour JM, Mital S, O'Byrne ML, Smerling AJ, Chen JM, Mosca R, Addonizio LJ. Heart transplantation in children with markedly elevated pulmonary vascular resistance: impact of right ventricular failure on outcome. J Heart Lung Transplant. 2011;30:659-666. doi: 10.1016/j.healun.2010.12.007.
123. Richmond ME, Law YM, Das BB, Everitt MD, Kukreja M, Naftel DC, Kemna MS, Henderson HT, Beddows K, Fricker FJ, Mahle WT; Pediatric Heart Transplant Study Investigators. Elevated pre-transplant pulmonary vascular resistance is not associated with mortality in children without congenital heart disease: a multicenter study. J Heart Lung Transplant. 2015;34:448-456. doi: 10.1016/j.healun.2014.04.021.
124. Hoskote A, Carter C, Rees P, Elliott M, Burch M, Brown K. Acute right ventricular failure after pediatric cardiac transplant: predictors and long-term outcome in current era of transplantation medicine. J Thorac Cardiovasc Surg. 2010;139:146-153. doi: 10.1016/j.jtcvs.2009.08.020.
125. Heart Lung Transplant Registry Data. International Society for Heart & Lung Transplantation website. http://www.ishlt.org/registries/slides. aspslides=heartLungRegistry. Accessed May 29, 2014.
126. Mitchell MB, Campbell DN, Ivy D, Boucek MM, Sondheimer HM, Pietra B, Das BB, Coll JR. Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure. J Thorac Cardiovasc Surg. 2004;128:693-702. doi: 10.1016/j.jtcvs.2004.07.013.
127. Irving C, Parry G, O'Sullivan J, Dark JH, Kirk R, Crossland DS, Chaudhari M, Griselli M, Hamilton JR, Hasan A. Cardiac transplantation in adults with congenital heart disease. Heart. 2010;96:1217-1222. doi: 10.1136/hrt.2009.184713.
128. Wang RP, Liang CH, Huang MP, Liu H, Deng QP, Yang MF. Assessment of aortopulmonary collateral flow and pulmonary vascular growth using a 3.0 T magnetic resonance imaging system in patients who underwent bidirectional Glenn shunting. Eur J Cardiothorac Surg. 2012;41:e146-e153. doi: 10.1093/ejcts/ezs189.
129. Hsu RB, Chang CI, Lin FY, Chou NK, Chi NH, Wang SS, Chu SH. Heart transplantation in patients with liver cirrhosis. Eur J Cardiothorac Surg. 2008;34:307-312. doi: 10.1016/j.ejcts.2008.05.003.
130. Gopaldas RR, Chu D, Cornwell LD, Dao TK, Lemaire SA, Coselli JS, Bakaeen FG. Cirrhosis as a moderator of outcomes in coronary artery bypass grafting and off-pump coronary artery bypass operations: a 12-year population-based study. Ann Thorac Surg. 2013;96:1310-1315. doi: 10.1016/j.athoracsur.2013.04.103.
131. Ailawadi G, Lapar DJ, Swenson BR, Siefert SA, Lau C, Kern JA, Peeler BB, Littlewood KE, Kron IL. Model for end-stage liver disease predicts mortality for tricuspid valve surgery. Ann Thorac Surg. 2009;87:1460-1467. doi: 10.1016/j.athoracsur.2009.01.043.
132. Kim MS, Kato TS, Farr M, Wu C, Givens RC, Collado E, Mancini DM, Schulze PC. Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction. J Am Coll Cardiol. 2013;61:2253-2261. doi: 10.1016/j.jacc.2012.12.056.
133. Chokshi A, Cheema FH, Schaefle KJ, Jiang J, Collado E, Shahzad K, Khawaja T, Farr M, Takayama H, Naka Y, Mancini DM, Schulze PC. Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction. J Heart Lung Transplant. 2012;31:591-600. doi: 10.1016/j.healun.2012.02.008.
134. Matthews JC, Pagani FD, Haft JW, Koelling TM, Naftel DC, Aaronson KD. Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality. Circulation. 2010;121:214-220. doi: 10.1161/CIRCULATIONAHA.108.838656.
135. Bonde P, Ku NC, Genovese EA, Bermudez CA, Bhama JK, Ciarleglio MM, Cong X, Teuteberg JJ, Kormos RL. Model for end-stage liver disease score predicts adverse events related to ventricular assist device therapy. Ann Thorac Surg. 2012;93:1541-1547. doi: 10.1016/j. athoracsur.2012.02.008.
136. Assenza GE, Graham DA, Landzberg MJ, Valente AM, Singh MN, Bashir A, Fernandes S, Mortele KJ, Ukomadu C, Volpe M, Wu F. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery. Heart. 2013;99:491-496. doi: 10.1136/heartjnl-2012-303347.
137. Fong TL, Hou L, Hutchinson IV, Cicciarelli JC, Cho YW. Impact of hepatitis C infection on outcomes after heart transplantation. Transplantation. 2009;88:1137-1141. doi: 10.1097/TP.0b013e3181bd3e59.
138. Wang A, Book WM, McConnell M, Lyle T, Rodby K, Mahle WT. Prevalence of hepatitis C infection in adult patients who underwent congenital heart surgery prior to screening in 1992. Am J Cardiol. 2007;100:1307-1309. doi: 10.1016/j.amjcard.2007.05.059.
139. Eason JD, Gonwa TA, Davis CL, Sung RS, Gerber D, Bloom RD. Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK). Am J Transplant. 2008;8:2243-2251. doi: 10.1111/j.1600-6143.2008.02416.x.
140. Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, Escorsell A, Garcia-Pagan JC, Patch D, Matloff DS, Gao H, Makuch R; Portal Hypertension Collaborative Group. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005;353:2254-2261. doi: 10.1056/NEJMoa044456.
141. Kim MY, Cho MY, Baik SK, Park HJ, Jeon HK, Im CK, Won CS, Kim JW, Kim HS, Kwon SO, Eom MS, Cha SH, Kim YJ, Chang SJ, Lee SS. Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension. J Hepatol. 2011;55:1004-1009. doi: 10.1016/j.jhep.2011.02.012.
142. Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Bosch J; Portal Hypertension Collaborative Group. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133:481-488. doi: 10.1053/j. gastro.2007.05.024.
143. Hsia TY, Khambadkone S, Deanfield JE, Taylor JF, Migliavacca F, De Leval MR. Subdiaphragmatic venous hemodynamics in the Fontan circulation. J Thorac Cardiovasc Surg. 2001;121:436-447. doi: 10.1067/mtc.2001.112527.
144. Elder RW, Parekh S, Book WM. More on hepatocellular carcinoma after the Fontan procedure. N Engl J Med. 2013;369:490. doi: 10.1056/NEJMc1306854.
145. Organ Procurement and Transplantation Network. Rockville, MD: US Department of Health & Human Services; 2015. Multiple organ transplants in the U.S. by recipient ABO: U.S. multi-organ transplants performed: January 1, 1988-July 31, 2015. Based on OPTN data as of October 30, 2015. http://optn.transplant.hrsa.gov/converge/latestData/rptData.asp. Accessed November 8, 2015.
146. Hollander SA, Reinhartz O, Maeda K, Hurwitz M, N Rosenthal D, Bernstein D. Intermediate-term outcomes after combined heart-liver transplantation in children with a univentricular heart. J Heart Lung Transplant. 2013;32:368-370. doi: 10.1016/j.healun.2012.11.023.
147. Robinson JA, Driscoll DJ, O'Leary PW, Burkhart HM, Dearani JA, Daly RC, Edwards BS, Dahl SH, Johnson JN. Cardiac and multiorgan transplantation for end-stage congenital heart disease. Mayo Clin Proc. 2014;89:478-483. doi: 10.1016/j.mayocp.2013.11.019.
148. Griffiths ER, Kaza AK, Wyler von Ballmoos MC, Loyola H, Valente AM, Blume ED, del Nido P. Evaluating failing Fontans for heart transplantation: predictors of death. Ann Thorac Surg. 2009;88:558-563. doi: 10.1016/j.athoracsur.2009.03.085.
149. Van De Bruaene A, La Gerche A, Claessen G, De Meester P, Devroe S, Gillijns H, Bogaert J, Claus P, Heidbuchel H, Gewillig M, Budts W. Sildenafil improves exercise hemodynamics in Fontan patients. Circ Cardiovasc Imaging. 2014;7:265-73. doi: 10.1161/CIRCIMAGING.113.001243.
150. Baek JS, Bae EJ, Ko JS, Kim GB, Kwon BS, Lee SY, Noh CI, Park EA, Lee W. Late hepatic complications after Fontan operation; non-invasive markers of hepatic fibrosis and risk factors. Heart. 2010;96:1750-1755. doi: 10.1136/hrt.2010.201772.
151. Simpson KE, Esmaeeli A, Khanna G, White F, Turnmelle Y, Eghtesady P, Boston U, Canter CE. Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function. J Heart Lung Transplant. 2014;33:170-177. doi: 10.1016/j. healun.2013.10.033.
152. Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation. 2007;115:1039-1050. doi: 10.1161/CIRCULATIONAHA.105.592386.
153. Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Dobbels F, Kirk R, Rahmel AO, Stehlik J, Hertz MI; International Society of Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heartlung transplant report-2012. J Heart Lung Transplant. 2012;31:1073-1086. doi: 10.1016/j.healun.2012.08.004.
154. Dimopoulos K, Inuzuka R, Goletto S, Giannakoulas G, Swan L, Wort SJ, Gatzoulis MA. Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension. Circulation. 2010;121:20-25. doi: 10.1161/CIRCULATIONAHA.109.883876.
155. Waddell TK, Bennett L, Kennedy R, Todd TR, Keshavjee SH. Heartlung or lung transplantation for Eisenmenger syndrome. J Heart Lung Transplant. 2002;21:731-737.
156. Paniagua Martín MJ, Almenar L, Brossa V, Crespo-Leiro MG, Segovia J, Palomo J, Delgado J, González-Vílchez F, Manito N, Lage E, Garciá-Guereta L, Rodríguez-Lambert JL, Albert DC. Transplantation for complex congenital heart disease in adults: a subanalysis of the Spanish Heart Transplant Registry. Clin Transplant. 2012;26:755-763. doi: 10.1111/j.1399-0012.2012.01611.x.
157. Kilic A, Allen JG, Weiss ES. Validation of the United States-derived Index for Mortality Prediction After Cardiac Transplantation (IMPACT) using international registry data. J Heart Lung Transplant. 2013;32:492-498. doi: 10.1016/j.healun.2013.02.001.
158. Burchill LJ, Edwards LB, Dipchand AI, Stehlik J, Ross HJ. Impact of adult congenital heart disease on survival and mortality after heart transplantation. J Heart Lung Transplant. 2014;33:1157-1163. doi: 10.1016/j. healun.2014.05.007.
159. Singh TP, Almond CS, Semigran MJ, Piercey G, Gauvreau K. Risk prediction for early in-hospital mortality following heart transplantation in the United States. Circ Heart Fail. 2012;5:259-266. doi: 10.1161/CIRCHEARTFAILURE.111.965996.
160. Karamlou T, Diggs BS, Welke K, Tibayan F, Gelow J, Guyton SW, Slater MS, Broberg C, Song HK. Impact of single-ventricle physiology on death after heart transplantation in adults with congenital heart disease. Ann Thorac Surg. 2012;94:1281-1287. doi: 10.1016/j. athoracsur.2012.05.075.
161. Russo MJ, Chen JM, Sorabella RA, Martens TP, Garrido M, Davies RR, George I, Cheema FH, Mosca RS, Mital S, Ascheim DD, Argenziano M, Stewart AS, Oz MC, Naka Y. The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg. 2007;133:554-559. doi: 10.1016/j.jtcvs.2006.09.019.
162. Maxwell BG, Wong JK, Sheikh AY, Lee PH, Lobato RL. Heart transplantation with or without prior mechanical circulatory support in adults with congenital heart disease. Eur J Cardiothorac Surg. 2014;45:842-846. doi: 10.1093/ejcts/ezt498.
163. Sugiura T, Kurosawa H, Shin'oka T, Kawai A. Successful explantation of ventricular assist device for systemic ventricular assistance in a patient with congenitally corrected transposition of the great arteries. Interact Cardiovasc Thorac Surg. 2006;5:792-793. doi: 10.1510/icvts.2006.139337.
164. Joyce DL, Crow SS, John R, St Louis JD, Braunlin EA, Pyles LA, Kofflin P, Joyce LD. Mechanical circulatory support in patients with heart failure secondary to transposition of the great arteries. J Heart Lung Transplant. 2010;29:1302-1305. doi: 10.1016/j.healun.2010.05.030.
165. Jouan J, Grinda JM, Bricourt MO, Iserin L, Fabiani JN. Non-pulsatile axial flow ventricular assist device for right systemic ventricle failure late after Senning procedure. Int J Artif Organs. 2009;32:243-245.
166. Neely RC, Davis RP, Stephens EH, Takayama H, Khalpey Z, Ginns J, Lee SH, Chen J. Ventricular assist device for failing systemic ventricle in an adult with prior Mustard procedure. Ann Thorac Surg. 2013;96:691-693. doi: 10.1016/j.athoracsur.2012.12.049.
167. Fishberger SB, Asnes JD, Rollinson NL, Cleman MW. Percutaneous right ventricular support during catheter ablation of intra-atrial reentrant tachycardia in an adult with a mustard baffle: a novel use of the Impella device. J Interv Card Electrophysiol. 2010;29:69-72. doi: 10.1007/s10840-010-9478-4.
168. Strueber M, Schmitto JD, Kutschka I, Haverich A. Placement of 2 implantable centrifugal pumps to serve as a total artificial heart after cardiectomy. J Thorac Cardiovasc Surg. 2012;143:507-509. doi: 10.1016/j. jtcvs.2011.07.034.
169. Morales DL, Adachi I, Heinle JS, Fraser CD Jr. A new era: use of an intracorporeal systemic ventricular assist device to support a patient with a failing Fontan circulation. J Thorac Cardiovasc Surg. 2011;142:e138-e140. doi: 10.1016/j.jtcvs.2011.05.018.
170. Feldman D, Pamboukian SV, Teuteberg JJ, Birks E, Lietz K, Moore SA, Morgan JA, Arabia F, Bauman ME, Buchholz HW, Deng M, Dickstein ML, El-Banayosy A, Elliot T, Goldstein DJ, Grady KL, Jones K, Hryniewicz K, John R, Kaan A, Kusne S, Loebe M, Massicotte MP, Moazami N, Mohacsi P, Mooney M, Nelson T, Pagani F, Perry W, Potapov EV, Eduardo Rame J, Russell SD, Sorensen EN, Sun B, Strueber M, Mangi AA, Petty MG, Rogers J; International Society for Heart and Lung Transplantation. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013;32:157-187. doi: 10.1016/j.healun.2012.09.013.
171. Rossano JW, Kaufman BD, Rame JE. Ethical considerations related to the use of mechanical support in congenital heart disease. World J Pediatr Congenit Heart Surg. 2013;4:70-74. doi: 10.1177/2150135112469040.
172. Almond CS, Singh TP, Gauvreau K, Piercey GE, Fynn-Thompson F, Rycus PT, Bartlett RH, Thiagarajan RR. Extracorporeal membrane oxygenation for bridge to heart transplantation among children in the United States: analysis of data from the Organ Procurement and Transplant Network and Extracorporeal Life Support Organization Registry. Circulation. 2011;123:2975-2984. doi: 10.1161/CIRCULATIONAHA.110.991505.
173. Morales DL, Almond CS, Jaquiss RD, Rosenthal DN, Naftel DC, Massicotte MP, Humpl T, Turrentine MW, Tweddell JS, Cohen GA, Kroslowitz R, Devaney EJ, Canter CE, Fynn-Thompson F, Reinhartz O, Imamura M, Ghanayem NS, Buchholz H, Furness S, Mazor R, Gandhi SK, Fraser CD Jr. Bridging children of all sizes to cardiac transplantation: the initial multicenter North American experience with the Berlin Heart EXCOR ventricular assist device. J Heart Lung Transplant. 2011;30:1-8. doi: 10.1016/j.healun.2010.08.033.
174. Almond CS, Morales DL, Blackstone EH, Turrentine MW, Imamura M, Massicotte MP, Jordan LC, Devaney EJ, Ravishankar C, Kanter KR, Holman W, Kroslowitz R, Tjossem C, Thuita L, Cohen GA, Buchholz H, St Louis JD, Nguyen K, Niebler RA, Walters HL 3rd, Reemtsen B, Wearden PD, Reinhartz O, Guleserian KJ, Mitchell MB, Bleiweis MS, Canter CE, Humpl T. Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children. Circulation. 2013;127:1702-1711. doi: 10.1161/CIRCULATIONAHA.112.000685.
175. Fraser CD Jr, Jaquiss RD, Rosenthal DN, Humpl T, Canter CE, Blackstone EH, Naftel DC, Ichord RN, Bomgaars L, Tweddell JS, Massicotte MP, Turrentine MW, Cohen GA, Devaney EJ, Pearce FB, Carberry KE, Kroslowitz R, Almond CS; Berlin Heart Study Investigators. Prospective trial of a pediatric ventricular assist device. N Engl J Med. 2012;367:532-541. doi: 10.1056/NEJMoa1014164.
176. Eghtesady P, Almond CS, Tjossem C, Epstein D, Imamura M, Turrentine M, Tweddell J, Jaquiss RD, Canter C; Berlin Heart Investigators. Posttransplant outcomes of children bridged to transplant with the Berlin Heart EXCOR Pediatric ventricular assist device. Circulation. 2013;128(suppl 1):S24-S31. doi: 10.1161/CIRCULATIONAHA.112.000446.
177. Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol. 2010;56:1149-1157. doi: 10.1016/j.jacc.2010.03.085.